20 results
PRE 14A
RVNC
Revance Therapeutics Inc
12 Mar 21
Preliminary proxy
4:13pm
committee financial expert” within the meaning of the SEC regulations. Our Board has determined that the composition of our Audit Committee meets
10-K
nzthozu t0
28 Mar 14
Annual report
12:00am
424B4
28ya5u7mxxyau
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
EX-10.12
rw92h 2j6
31 Dec 13
IPO registration
12:00am
S-1
r229ze93d
31 Dec 13
IPO registration
12:00am
DRS
6y61y9pddefajj9nk
19 Apr 13
Draft registration statement
12:00am
DRS
EX-10.12
bxa6f4yzokpcw802ohpb
19 Apr 13
Draft registration statement
12:00am
- Prev
- 1
- Next